Abstract
In view of their expected anticonvulsant activity, some novel derivatives of 5-chloro-2-substituted sulfanylbenzoxazoles (5–15f) were synthesized and evaluated for their anticonvulsant activity against pentylenetetrazole-induced seizures in mice. The molecular docking was performed for all the synthesized compounds to assess their binding affinities to KCNQ2 receptor in order to rationalize their anticonvulsant activities in a qualitative way. The data obtained from the molecular modeling were correlated with that obtained from the biological screening. These data revealed that compounds 15f, 7c, 15b, and 15d showed the highest binding affinities toward KCNQ2 receptor along with the highest anticonvulsant activities in experimental mice. The highest active compounds showed relative potencies of 0.98, 0.94, 0.91, and 0.83, respectively, in comparing to phenobarbital sodium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Aziz M, Abuo-Rahma GEA, Hassan AA (2009) Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur J Med Chem 44(9):3480–3487
Bansal M, Goel B, Shukla S, Shyam R, Srivastava SR (2012) Synthesis, characterization & anticonvulsant activity of amide derivatives of 4-amino-1,2-naphthoquinone. Med Chem Res 22(11):5349–5355
Baum B, Mohamed M, Zayed M, Gerlach C, Heine A, Hangauer D, Klebe G (2009) More than a simple lipophilic contact: a detailed thermodynamic analysis of non basic residues in the S1 pocket of thrombin. J Mol Biol 390(1):56–69
Bayoumi A, Ghiaty A, El-Morsy A, Abul-Khair H, Hassan MH, Elmeligie S (2012) Synthesis and evaluation of some new 1,2,4-triazolo(4,3-a)quinoxalin-4-5H-one derivatives as AMPA receptor antagonists. Bull Fac Pharm Cairo Univ 50(2):141–146
Davood A, Amini M, Azimidoost L, Rahmatpour S, Nikbakht Ali, Iman M, Shafaroodi H, Ansari A (2013) Docking, synthesis, and pharmacological evaluation of isoindoline derivatives as anticonvulsant agents. Med Chem Res 22(7):3177–3184
Debska G, Kicinska A, Dobrucki J, Dworakowska B, Nurowska E, Skalska J, Dolowy K, Szewczyk A (2003) Large-conductance K channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells. Biochem Pharmacol 65:1827–1834
El-Adl K (2011) Design and synthesis of some novel 2-(5-methylbenzoxazol-2-ylsalfanyl)-N-(4-substitutedphenyl)acetamide derivatives with potential anticonvulsant activity. Az J Pharm Sci 44:183–204
Elhelby AA, Ayyad RR, Zayed MF (2011) Synthesis and biological evaluation of some novel quinoxaline derivatives as anticonvulsant agents. Arzneimittelforschung 61(7):379–381
El-Helby AA, Ibrahim MK, Abdel-Rahman AA, Ayyad RRA, Menshawy MA, El-Adl K (2009) Synthesis, molecular modeling and anticonvulsant activity of benzoxazole derivatives. Az J Pharm Sci 40:252–270
Englert L, Biela A, Zayed M, Heine A, Hangauer D, Klebe G (2010) Displacement of disordered water molecules from hydrophobic pocket creates enthalpic signature: binding of phosphonamidate to the S1′-pocket of thermolysin. Biochim Biophys Acta 1800:1192–1202
Gil-Nagel A, Brodie JM, Leroyc R, Cyrd T, Hall S, Castiglia M, Colleen Twomeye C, Landinghame VK (2012) Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: interim results from two ongoing open-label studies. Epilepsy Res 102:117–121
Husain A, Rashid M, Akhter A, Mishra R (2011) Synthesis of new 1,2,4-triazolo[3,4-B][1,3,4]thiadiazole derivatives and their Pharmacological evaluation. J Pharmacy Res 4(3):888–890
Ibrahim MK, Abdel-Rahman AA, Ayyad RRA, El-Adl K, El-sherbeny F, Rashed M (2010) Design and synthesis of some novel N-phthalimide derivatives with potential anticonvulsant activity. Az J Pharm Sci 42:305–322
Ibrahim MK, Abd-Elrahman AA, Ayyad RRA, El-Adl K, Mansour AM, Eissa IH (2013) Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)phenyl)-acetamide derivatives for biological evaluation as anticonvulsant agents. Bull Fac Pharm Cairo Univ 51(1):101–111
Ilangovan P, Ganguly S, Pandi V (2010) Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agent. J Pharmacy Res 3(4):703–706
Meldrum BS, Rogawski MA (2007) Molecular targets for antiepileptic drug development. Neurotherapeutics 4:18–61
Muthukumar VA, Ramasamy S, Yadav SK, Gobala KP, Palani S (2011) Synthesis, characterization and molecular docking studies of novel 2,5-disubstitutedthiadiazole and oxadiazole derivatives. J Pharmacy Res 4(12):4658–4660
Peretz A, Degani N, Nachman R, Uziyel Y, Gibor G, Shabat D, Attali B (2005) Meclofenamic acid and Diclofenac, novel templates of KCNQ2/Q3 Potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 67(4):1053–1066
Rogawski MA, Bazil CW (2008) New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep 8(4):345–352
Smitha S, Pandeya SN, Stables JP, Ganapathy S (2008) Anticonvulsant and sedative-hypnotic activities of N-Acetyl/methyl isatin derivatives. Sci Pharm 76:621–636
Vogel GH (2008) Drug Discovery and Evaluation: Pharmacological Assays, 3rd edn, Springer-Verlag, New York 692-693
Wei CX, Guan LP, Jia JH, Chai KY, Quan ZS (2009) Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents. Arch Pharm Res 32(1):23–31
Wu YJ, Sun LQ, He H, Chen J, Sarrett JE Jr, Dextraze P, Daris JP, Boissard CG, Pieschl RL, Gribkoff VK, Natale J, Knox RJ, Harden DG, Thompson MW, Fitzpatrick W, Weaver D, Wu D, Gao Q, Dworetzky SI (2004) Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxolo-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides. Bioorg Med Chem Lett 14(17):4533–4537
Zayed MF (2014) New fluorinated quinazolinone derivatives as anticonvulsant agents. J Taibah Univ Med Sci 9:104–109
Zayed MF, Ayyad RR (2012) Some novel anticonvulsant agents derived from phthalazinedione. Arzneimittelforschung 62:532–536
Zayed MF, Ahmed HEA, Omar AM, Abdelrahim AS, El-Adl K (2013) Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents. Med Chem Res 22(12):5823–5831
Zhang D, Thimmapaya R, Zhang XF, Anderson DJ, Baranowski JL, Scanio M, Perez-Medrano A, Peddi S, Wang Z, Patel JR, DeGoey DA, Gopalakrishnan M, Honore P, Yao BB, Surowy CS (2011) KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels. J Neurosci Methods 200(1):54–62
Zhou X, Wei J, Song M, Francis K, Yu SP (2011) Novel role of KCNQ2/3 channels in regulating neuronal cell viability. Cell Death Differ 18(3):493–505
Acknowledgments
The authors extend their appreciation and thanking to Prof. Dr. Ahmed M. Mansour, Pharmacology & Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt for helping in the pharmacological screening.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ibrahim, MK., El-Adl, K., Zayed, M.F. et al. Design, synthesis, docking, and biological evaluation of some novel 5-chloro-2-substituted sulfanylbenzoxazole derivatives as anticonvulsant agents. Med Chem Res 24, 99–114 (2015). https://doi.org/10.1007/s00044-014-1111-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1111-0